STAT

STAT+: Pharmalittle: Biden wins biotech support despite his policies; WHO sets Covid-19 compensation fund for low-income nations

From a policy perspective, Joe Biden should be biotech’s worst nightmare. But that isn’t stopping major biotech chief executives and investors from personally backing Biden's campaign.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall,, and catch up on our reading. And what about you? This may be your last chance to mail in your ballot. You could boost the economy by shopping for winter wear. Or wish upon a star and make the pandemic go away (wouldn’t that be nice?). Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks